Institution profile

高輪医院銀座

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2409022 +5

Location

Prefecture
Tokyo
Address
中央区銀座6-12-12 サクラマークス銀座612 8階、9階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • CONCIDE特定認定再生医療等委員会
  • CONCIDE 特定認定再生医療等委員会
  • +2

Public score

68.4/ 100

A · Review level
25.0 / 30
B · Technologies
22.4 / 35
C · Coverage
14.3 / 25
D · Class I / II technologies
6.7 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 68.4
Public score →100

Registered technologies (6)

Stem cells (all sources) 3
Registered technologies · Japanese originalTechnology areasPlan classification
ヒト自己脂肪組織由来間葉系幹細胞を用いた疼痛緩和治療Stem cells (all sources)Adipose-derived stem cellsClass II
糖尿病及び境界型糖尿病に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞による慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
ヒト自己脂肪組織由来間葉系幹細胞を用いた疼痛緩和治療Stem cells (all sources)Adipose-derived stem cellsClass II
糖尿病及び境界型糖尿病に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞による慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
PRP and platelet-derived 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己多血小板血漿(PRP)を用いた加齢性変化(しみ、しわ、たるみ、にきび跡)に対する治療PRP and platelet-derivedSkinClass III
NK and immune cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
ヒト自己活性化NK細胞による免疫細胞療法NK and immune cellsClass III
Skin 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己多血小板血漿(PRP)を用いた加齢性変化(しみ、しわ、たるみ、にきび跡)に対する治療PRP and platelet-derivedSkinClass III
Other 1
Registered technologies · Japanese originalTechnology areasPlan classification
自家培養真皮線維芽細胞移植術OtherClass II

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • CONCIDE特定認定再生医療等委員会
  • CONCIDE 特定認定再生医療等委員会
  • CONCIDE認定再生医療等委員会
  • ICTA特定認定再生医療等委員会

Public document number

  • 01C2409022
  • 02C2411018
  • 03C2607002
  • 03C2607003
  • 02C2409065
  • 02C2410012
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
糖尿病及び境界型糖尿病に対する自己脂肪由来幹細胞による治療Class IIJSCSF再生医療等委員会01C2409022
自己脂肪由来幹細胞による慢性疼痛の治療Class IICONCIDE特定認定再生医療等委員会02C2411018
ヒト自己脂肪組織由来間葉系幹細胞を用いた疼痛緩和治療Class IICONCIDE 特定認定再生医療等委員会03C2607002
自家培養真皮線維芽細胞移植術Class IICONCIDE 特定認定再生医療等委員会03C2607003
自己多血小板血漿(PRP)を用いた加齢性変化(しみ、しわ、たるみ、にきび跡)に対する治療Class IIICONCIDE認定再生医療等委員会02C2409065
ヒト自己活性化NK細胞による免疫細胞療法Class IIIICTA特定認定再生医療等委員会02C2410012

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor